Wikidata

(Q65337161)

English

PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor R

clinical trial

In more languages

Statements

short name
PALLAS (English)
0 references
title
PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer (English)
0 references
country
Australia
0 references
Canada
0 references
Israel
0 references
Japan
0 references
Mexico
0 references
Switzerland
0 references
Taiwan
0 references
start time
August 2015
0 references
end time
September 2020
0 references
number of participants
5,792
0 references
research site
Stanford University
0 references
Georgetown University
0 references
University of Miami
0 references
Mercy Medical Center
0 references
Mayo Clinic
0 references
Coborn Cancer Center
0 references
Dartmouth University
0 references
UNM Los Lunas
0 references
New York University
0 references
University at Buffalo
0 references
Cleveland Clinic
0 references
Ohio State University
0 references
Rhode Island Hospital
0 references
Royal Hobart Hospital
0 references
Barwon Health
0 references
Fiona Stanley Hospital
0 references
BC Cancer Agency
0 references
University of Toronto
0 references
Tel Aviv University
0 references
Hospital Luzern
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65337161&oldid=2079006189"